Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
Clinical trial NCT06323369 · RECRUITING
Trial details
- NCT number
- NCT06323369
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2029-03-25
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.